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Dear Editor,
A 59-year-old man presented with a 9-month history of
transfusion-dependent anaemia, hepatomegaly (2 cm)
and splenomegaly (6 cm). F-18 fluorodeoxyglucose
(FDG) positron emission tomography computed tomog-
raphy (PET/CT) showed gross hepatosplenomegaly
(Fig. 1a) that was eumetabolic (Fig. 1b), raising the
possibility that the cause might be non-neoplastic.
However, bone marrow examination showed a small
population of suspicious T cells with no clear histopath-
ological patterns. The T cell receptor (TCR) gamma gene
was clonally rearranged on polymerase chain reaction,
suggesting that the hepatosplenomegaly might be related
to a clonal T cell neoplasm.
Splenectomy and liver biopsy were performed. Histo-
logically, there was cord expansion and sinusoidal
infiltration in the splenic red pulp by small atypical
lymphoid cells (Fig. 1c). These neoplastic lymphoid cells
were also found as small aggregates in the hepatic
sinusoids (Fig. 1d). On immunophenotyping, the lym-
phoid cells were CD3+, CD4−,C D 8 −,T I A - 1 + ,T C R β−
and TCRγ+( F i g .1e–h). The overall features were
consistent with hepatosplenic T cell lymphoma (HSTCL)
of the γδ subtype.
PET/CT is used extensively in the staging and post-
treatment follow-up of Hodgkin's lymphoma, where it is
considered a standard of care [1]. It is also regarded as
highly sensitive in most aggressive and indolent B cell
lymphomas [2]. FDG uptake is usually proportional to
histopathological grading, being very avid in high-grade
lymphomas that are metabolically active. Although this
pattern is generally observed in B cell lymphomas, it is
undefined if FDG uptake also parallels the clinical
behaviour in T cell lymphomas. In fact, PET/CT has
been reported to be negative in some T cell malignan-
cies, notably T-large granular lymphocyte leukaemia and
T-prolymphocytic leukaemia [3]. HSTCL is an aggressive
lymphoma with a poor survival. It accounts for less than
1% of all lymphomas. Because HSTCL is rare, the
application of PET/CT in its diagnosis and management
has not been evaluated. FDG avidity had only been
previously reported in a single case of HSTCL occurring
after liver transplantation [4]. Our case apparently had
arisen de novo. The lymphoma was entirely FDG non-
avid, constituting a diagnostic pitfall. Therefore, the role
of PET/CT in the diagnosis and follow-up of T cell
lymphomas may have to be carefully defined for each
histopathological type [5].
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Fig. 1 A case of hepatosplenic T cell lymphoma with negative
positron emission tomography. a Computed tomography of the
abdomen, showing gross hepatosplenomegaly. b Positron emission
tomography showing that the hepatosplenomegaly was eumetabolic. c
The spleen showed red pulp infiltration by atypical lymphoid cells. d
The liver showed infiltration of sinusoids (arrows) by atypical
lymphoid cells. e–h Immunoperoxidase staining, showing that the
lymphoma cells were positive for CD3 (e), negative for CD4 and CD8
(f, g), and positive for TCRγ (h)
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